Celon Pharma (FRA:8RP) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 09, 2026)


FRA:8RP Celon Pharma SA FRA:8RP
12 GF Score
Price €4.36
GF Value €5.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Celon Pharma Float Percentage Of Total Shares Outstanding?

Celon Pharma FRA:8RP 12 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus rates FRA:8RP with a GF Score™ of 12/100 and a GF Value™ of €5.14 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Celon Pharma's float shares is 0.00 Mil. Celon Pharma's total shares outstanding is 38.91 Mil. Celon Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Celon Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Celon Pharma's Institutional Ownership is 0.23%.

FRA:8RP
12GF Score
Celon Pharma SA FRA:8RP
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celon Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Celon Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/38.91
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Celon Pharma (FRA:8RP) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Celon Pharma and its competitors.
Is Celon Pharma's Float Percentage Of Total Shares Outstanding too high?
Celon Pharma's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Celon Pharma has a GF Score™ of 12/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Celon Pharma's Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Celon Pharma's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Celon Pharma and its competitors. Celon Pharma's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celon Pharma stock overvalued right now?
Based on GuruFocus' analysis, Celon Pharma (FRA:8RP) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.14, compared to a current price of €4.36 — trading 15.3% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Celon Pharma's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Celon Pharma (FRA:8RP), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Celon Pharma (FRA:8RP) Overvalued in 2026?

Based on GuruFocus' analysis, Celon Pharma stock appears to be undervalued. The current stock price of €4.36 is trading 15.3% below its estimated GF Value™ of €5.14. GuruFocus considers Celon Pharma to be Modestly Undervalued.

Key valuation signals for FRA:8RP:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €5.14 vs. price of €4.36 (15.3% below fair value)
  • GF Score™: 12/100 with 3 warning signs

No single metric tells the full story. See the FRA:8RP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Celon Pharma Business Description

Other Exchanges CLN:Poland
Address Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.
12GF Score

Get the complete analysis for FRA:8RP

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.36
Price
€5.14
GF Value